Related Experiment Video
Updated: Mar 1, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Mitral valve prolapse and Marfan syndrome
1Department of Cardiac Surgery, Leeds General Infirmary, Great George Street, Leeds, United KIngdom.
Abstract:
Marfan syndrome is a multisystemic genetic condition affecting connective tissue. It carries a reduced life expectancy, largely dependent on cardiovascular complications. More common cardiac manifestations such as aortic dissection and aortic valve incompetence have been widely documented in the literature. Mitral valve prolapse (MVP), however, has remained poorly documented. This article aims at exploring the existing literature on the pathophysiology and diagnosis of MVP in patients with Marfan syndrome, defining its current management and outlining the future developments surrounding it.
Insights
Marfan syndrome, a connective tissue disorder, often leads to cardiovascular issues. This review focuses on mitral valve prolapse (MVP) in Marfan syndrome, exploring its pathophysiology, diagnosis, and management.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Connective Tissue Disorders
Background:
- Marfan syndrome is a genetic disorder impacting connective tissue, significantly affecting life expectancy due to cardiovascular complications.
- While aortic dissection and valve incompetence are well-documented, mitral valve prolapse (MVP) in Marfan syndrome is less understood.
- Understanding MVP is crucial for comprehensive Marfan syndrome patient care.
Purpose of the Study:
- To review the current literature on the pathophysiology and diagnosis of mitral valve prolapse (MVP) in Marfan syndrome.
- To define the established management strategies for MVP in this patient population.
- To outline potential future research and clinical developments concerning MVP in Marfan syndrome.
Main Methods:
- Systematic literature review of studies on Marfan syndrome and mitral valve prolapse.
- Analysis of diagnostic criteria and imaging modalities for MVP in Marfan patients.
- Synthesis of current treatment guidelines and emerging therapeutic approaches.
Main Results:
- MVP is a frequent but under-recognized cardiac manifestation in Marfan syndrome.
- Pathophysiology involves myxomatous degeneration of mitral valve leaflets due to FBN1 gene mutations.
- Early diagnosis and tailored management are key to improving outcomes.
Conclusions:
- Mitral valve prolapse requires greater attention in the clinical evaluation of Marfan syndrome patients.
- Further research is needed to optimize diagnostic and therapeutic strategies for MVP in this population.
- Improved understanding and management of MVP can enhance the quality of life and prognosis for individuals with Marfan syndrome.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation I: Introduction
Mitral Stenosis III: Medical Management

